Stockscreener 앱 받기
18.50
3.99%
0.71
전일 마감가:
$17.79
열려 있는:
$17.71
하루 거래량:
1.40M
Relative Volume:
1.45
시가총액:
$814.46M
수익:
$78.02M
순이익/손실:
$-73.37M
주가수익비율:
-14.02
EPS:
-1.32
순현금흐름:
$-62.06M
1주 성능:
-8.14%
1개월 성능:
-37.56%
6개월 성능:
+46.13%
1년 성능:
+0.00%
1일 변동 폭
$17.39
$18.61
1주일 범위
$16.02
$20.30
52주 변동 폭
$8.89
$32.71
Beta Bionics Inc Stock (BBNX) Company Profile
명칭
Beta Bionics Inc
전화
949-427-7785
주소
11 HUGHES, IRVINE
BBNX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BBNX
Beta Bionics Inc
|
18.50 | 783.20M | 78.02M | -73.37M | -62.06M | -1.32 |
|
ABT
Abbott Laboratories
|
121.76 | 214.80B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.78 | 138.62B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
BSX
Boston Scientific Corp
|
88.07 | 133.46B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
96.76 | 126.92B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.35 | 49.03B | 5.88B | 1.34B | 799.60M | 2.3489 |
Beta Bionics Inc Stock (BBNX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-09 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2025-10-21 | 재개 | Stifel | Buy |
| 2025-10-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2025-06-16 | 개시 | Truist | Buy |
| 2025-06-12 | 개시 | Lake Street | Buy |
| 2025-05-30 | 개시 | Goldman | Neutral |
| 2025-05-30 | 개시 | Wolfe Research | Outperform |
| 2025-02-24 | 개시 | BofA Securities | Buy |
| 2025-02-24 | 개시 | Lake Street | Buy |
| 2025-02-24 | 개시 | Leerink Partners | Outperform |
| 2025-02-24 | 개시 | Piper Sandler | Overweight |
| 2025-02-24 | 개시 | Stifel | Buy |
| 2025-02-20 | 개시 | Ladenburg Thalmann | Neutral |
| 2025-02-20 | 개시 | Robert W. Baird | Neutral |
모두보기
Beta Bionics Inc 주식(BBNX)의 최신 뉴스
Bond Watch: Is Beta Bionics Inc a top pick in the sectorMarket Growth Report & Entry and Exit Point Strategies - baoquankhu1.vn
BETA BIONICS is Being Investigated for Potential Securities Law ViolationsContact Kaplan Fox & Kilsheimer LLP - The National Law Review
Bronstein, Gewirtz & Grossman, LLC Is Investigating Beta Bionics, Inc. (BBNX) And Encourages Stockholders to Connect - ACCESS Newswire
Midday Stock Roundup: loanDepot Jumps on Trump’s Proposed Mortgage Plan - Orange County Business Journal
SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - TMX Newsfile
Kaplan Fox Alerts Investors of Beta Bionics, Inc. (BBNX) to an Investigation of Possible Securities Law Violations - FinancialContent
Kaplan Fox is Investigating Beta Bionics, Inc. (BBNX) for Potential Securities Law Violations - The National Law Review
Beta Bionics to Announce Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026 - The Manila Times
Risk Analysis: Does Beta Bionics Inc have pricing powerQuarterly Profit Report & AI Based Trade Execution Alerts - baoquankhu1.vn
Laser Focus WorldKaplan Fox is Investigating Beta Bionics, Inc. (BBNX) for Potential Securities Law Violations - FinancialContent
Beta Bionics, Inc. Investigated on Behalf of InvestorsContact the DJS Law Group to Discuss Your RightsBBNX - 富途牛牛
Beta Bionics, Inc. (NASDAQ:BBNX) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
Beta Bionics Under Investigation for Securities Violations, Shares Plunge 37% - Intellectia AI
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm - PR Newswire
Kaplan Fox Announces an Investigation Into Beta Bionics, Inc. (BBNX) for Potential Securities Law Violations - The National Law Review
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm - GlobeNewswire Inc.
Estimating The Fair Value Of Beta Bionics, Inc. (NASDAQ:BBNX) - Yahoo Finance
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - TMX Newsfile
Kaplan Fox & Kilsheimer LLP is Investigating Beta Bionics, Inc. (BBNX) for Potential Securities Law Violations - FinancialContent
Beta Bionics shares plunge 43% after InvestingPro’s overvalued warning By Investing.com - Investing.com Nigeria
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Beha - GuruFocus
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics - The Joplin Globe
Securities Fraud Investigation Into Beta Bionics, Inc. (BBNX) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz - The AI Journal
About Us - FinancialContent
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Beta Bionics, Inc. (BBNX) And Encourages Investors to Reach Out - ACCESS Newswire
Midday Stock Roundup: Staar Down 4% on Board Changes - Orange County Business Journal
Beta Bionics (NASDAQ:BBNX) Shares Down 9.2% Following Analyst Downgrade - MarketBeat
Market Trends: Can Beta Bionics Inc deliver alphaEarnings Risk Summary & Verified Technical Signals - baoquankhu1.vn
Beta Bionics, Inc.'s (NASDAQ:BBNX) Popularity With Investors Under Threat As Stock Sinks 31% - 富途牛牛
Does Beta Bionics (BBNX) Strong Q4 Sales Outlook Reshape Confidence in Its Long-Term Strategy? - simplywall.st
Why Beta Bionics Inc. stock is a value investor pickMarket Sentiment Summary & Long-Term Growth Stock Strategies - Улправда
We're Hopeful That Beta Bionics (NASDAQ:BBNX) Will Use Its Cash Wisely - Sahm
Beta Bionics (NASDAQ:BBNX) Stock Rating Lowered by Wall Street Zen - MarketBeat
Beta Bionics Stock (-37%): Patient Growth Miss Spooks Street - Trefis
Beta Bionics Shares Plunge 37% Amid Investor Lawsuit Investigation - Intellectia AI
Beta Bionics stock to exceed Q4 revenue targets, Stifel maintains Buy By Investing.com - Investing.com South Africa
Beta Bionics Shares Fall After BofA Securities Downgrade - marketscreener.com
Midday Stock Roundup: loanDepot Rises on Trump Move - Orange County Business Journal
Beta Bionics Tumbles 32% on Analyst Downgrade - Orange County Business Journal
Beta Bionics stock tumbles following deceleration in new patient starts By Investing.com - Investing.com UK
Beta Bionics stock tumbles following deceleration in new patient starts - Investing.com
BofA Securities Downgrades Beta Bionics to Neutral From Buy, Adjusts Price Target to $28 From $33 - marketscreener.com
Beta Bionics stock to exceed Q4 revenue targets, Stifel maintains Buy - Investing.com Canada
Beta Bionics (NASDAQ:BBNX) Shares Gap Down Following Analyst Downgrade - MarketBeat
Premium Valuation and Slowing New Patient Growth Drive Shift to Neutral on Beta Bionics - TipRanks
Beta Bionics (NASDAQ:BBNX) Lowered to "Neutral" Rating by Bank of America - MarketBeat
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Beta Bionics Inc (BBNX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.42%
1.96%
자본화:
|
볼륨(24시간):